Predict your next investment

CONSUMER PRODUCTS & SERVICES | Home Furnishings & Accessories
ergopack.ua

See what CB Insights has to offer

Stage

Acquired | Acquired

About Ergopack

Ergopack produces and supplies goods that facilitate the maintenance of cleanliness and food prepration for households and professional users.

Ergopack Headquarter Location

36 Sobornosti Str., p/b №349 Boyarka City

Kiev, 08154,

Ukraine

+38 044 507 18 54

Latest Ergopack News

Teleflex Delivers COMPLETE Confidence with the New Arrow® ErgoPack® Complete CVC System

Oct 27, 2020

| Source: Teleflex Incorporated WAYNE, Pa., Oct. 27, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) delivers COMPLETE confidence to central line inserters with the release of the Arrow® ErgoPack® Complete CVC System, the most important update to its market-leading1 portfolio of Centrally-Inserted Central Catheters in more than a decade. Teleflex conducted extensive research with industry-leading vascular access professionals to select the enhancements in the new ErgoPack® Complete System. Clinician-inspired updates to the kit include: The Arrow GlideWheel™ Advancer, which provides tactile feedback and finer control Nitinol Guidewire, which is kink-resistant compared to stainless steel Transducer Cover to support guidelines for ultrasound use Pre-filled sterile saline syringes, one per catheter lumen Extra ChloraPrep® Skin Prep in each kit (two total) “The ErgoPack® Complete System is built with the inserter in mind, first and foremost,” said Jake Newman, President and General Manager, Teleflex Vascular. “The ErgoPack® Complete System is a powerful tool in the fight against CLABSI.1” These new additions enhance the already-considerable power of the market-leading2 ErgoPack® System, which features, at its heart, Teleflex’s Arrowg+ard Blue Plus® CVC. It’s the only full-spectrum antimicrobial CVC that protects against gram-positive, gram-negative bacteria and fungi, the key infectious pathogens responsible for CLABSI. CLABSI is responsible for as many as 28,000 deaths per year in the US.3 The ErgoPack® Complete System’s unique combination of CVC insertion components, packaged in an ergonomic and efficient top down, left to right configuration, helps central line inserters comply with critical third party independent guidelines for reducing CLABSI, including: Centers for Disease Control and Prevention (CDC) Category 1A & 1B recommendations4 Society for Hospital Epidemiology of America (SHEA) Guidelines5 Infusion Nursing Society (INS) Standards of Practice6 Occupational Health and Safety Administration (OSHA) Bloodborne Pathogens Standard7 The ErgoPack® Complete System is available in two different configurations, in a variety of catheter French sizes. Learn more at  http://go.teleflex.com/CompleteConfidence About Teleflex Incorporated Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com . Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift®, and Weck® – trusted brands united by a common sense of purpose. Forward-Looking Statements Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K. Rx only Contraindication: The Arrowg+ard Blue Plus® CVC is contraindicated for patients with known hypersensitivity to chlorhexidine and silver sulfadiazine and/or sulfa drugs. Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Plus, Deknatel, ErgoPack, GlideWheel, Hudson RCI, LMA, Pilling, Rusch, UroLift, and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other marks are the property of their respective owners. © 2020 Teleflex Incorporated. All rights reserved. MC-006733 References: 1. Raad, II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infection Control and Hospital Epidemiology. 1994;15(4 Pt 1): 231-238. DRG data. Teleflex. 2020. O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011 (Revised 2017). 2. Atlanta, GA: Centers for Disease Control and Prevention; 2017. Marschall J, Mermel LA, Fakih M, et al. Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals: 2014 Update. Infection Control and Hospital Epidemiology. 2014 July; 35(7): 753-71. Gorski L, Hadaway L, Hagle ME, McGoldrick M, et al. Infusion Therapy Standards of Practice. Journal of Infusion Nursing. 2016; Jan 39(1S). Occupational Safety & Health Administration Regulations (Standards – 29 CFR). Part 1910.1030: Bloodborne pathogens. Occupational Safety & Health Administration Web site. https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.1030 . Accessed on February 12, 2020. Source:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Ergopack Patents

Ergopack has filed 3 patents.

The 3 most popular patent topics include:

  • Graphical projections
  • Packaging machinery
  • Technical drawing
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/20/2020

5/4/2021

Packaging machinery, Industrial automation, Digital movie cameras, Technical drawing, Graphical projections

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

1/20/2020

00/00/0000

00/00/0000

Grant Date

5/4/2021

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Packaging machinery, Industrial automation, Digital movie cameras, Technical drawing, Graphical projections

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.